Literature DB >> 20554812

Comparison of an automated repetitive-sequence-based PCR microbial typing system with pulsed-field gel electrophoresis for molecular typing of vancomycin-resistant Enterococcus faecium.

Yu-Chung Chuang1, Jann-Tay Wang, Mei-Ling Chen, Yee-Chun Chen.   

Abstract

Vancomycin-resistant Enterococcus faecium (VRE) has become an important health care-associated pathogen because of its rapid spread, limited therapeutic options, and possible transfer of vancomycin resistance to more-virulent pathogens. In this study, we compared the ability to detect clonal relationships among VRE isolates by an automated repetitive-sequence-based PCR (Rep-PCR) system (DiversiLab system) to pulsed-field gel electrophoresis (PFGE), the reference method for molecular typing of VRE. Two sets of VRE isolates evaluated in this study were collected by active microbial surveillance at a large teaching hospital in Taiwan during 2008. The first set included 90 isolates randomly selected from the surveillance cohort. The first set consisted of 34 pulsotypes and 10 Rep-PCR types. There was good correlation between the two methods (P < 0.001). The second set included 68 VRE isolates collected from eight clusters of colonization. A dominant clone was detected in five out of eight clusters by both methods. Two clusters were characterized by Rep-PCR as being caused by a dominant clone, whereas PFGE showed polyclonal origins. One cluster was shown to be polyclonal by both methods. A single Rep-PCR clone type was detected among 12 of 14 vancomycin-intermediate enterococci, whereas PFGE detected six pulsotypes. In conclusion, the Rep-PCR method correlated well with PFGE typing but was less discriminative than PFGE in defining clonal relationships. The ease of use and more rapid turnaround time of Rep-PCR compared to PFGE offers a rapid screening method to detect outbreaks of VRE and more rapidly implement control measures. PFGE remains the preferred method to confirm clonal spread.

Entities:  

Mesh:

Year:  2010        PMID: 20554812      PMCID: PMC2916582          DOI: 10.1128/JCM.00136-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-08-06       Impact factor: 17.586

6.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

7.  Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital.

Authors:  J-T Wang; Y-C Chen; S-C Chang; M-L Chen; H-J Pan; Y-Y Chang; C-C Sun; L-H Wang; S-H Wang; H-C Lin; S-F Chien; M-S Tseng
Journal:  J Hosp Infect       Date:  2004-10       Impact factor: 3.926

8.  Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus.

Authors:  W C Noble; Z Virani; R G Cree
Journal:  FEMS Microbiol Lett       Date:  1992-06-01       Impact factor: 2.742

9.  Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-09-22

Review 10.  New technology for detecting multidrug-resistant pathogens in the clinical microbiology laboratory.

Authors:  L R Peterson; G A Noskin
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  17 in total

1.  Investigation of vancomycin resistant Enterococcus faecium outbreak in neonatal intensive care unit.

Authors:  Burcu Dalyan Cilo; Harun Ağca; Kadir Efe; Melda Sınırtaş; Solmaz Çelebi; Hilal Özkan; Nilgün Köksal; Mustafa Hacımustafaoğlu; Cüneyt Özakın
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Controlled performance evaluation of the DiversiLab repetitive-sequence-based genotyping system for typing multidrug-resistant health care-associated bacterial pathogens.

Authors:  Ariane Deplano; Olivier Denis; Hector Rodriguez-Villalobos; Raf De Ryck; Marc J Struelens; Marie Hallin
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

3.  Comparison of a semiautomated commercial repetitive-sequence-based PCR method with spoligotyping, 24-locus mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing, and restriction fragment length polymorphism-based analysis of IS6110 for Mycobacterium tuberculosis typing.

Authors:  F Brossier; C Sola; G Millot; V Jarlier; N Veziris; W Sougakoff
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

4.  Raman spectroscopic analysis of the clonal and horizontal spread of CTX-M-15-producing Klebsiella pneumoniae in a neonatal intensive care unit.

Authors:  K Guyot; V Biran; C Doit; D Moissenet; T Guillard; L Brasme; C Courroux; K Maquelin; W van Leeuwen; H Vuthien; Y Aujard; C De Champs; E Bingen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-27       Impact factor: 3.267

5.  Outbreak of vancomycin-resistant enterococcus on a haematology ward: management and control.

Authors:  Diego García Martínez de Artola; Beatriz Castro; María José Ramos; Zaida Díaz Cuevas; Sunil Lakhwani; María Lecuona
Journal:  J Infect Prev       Date:  2017-02-08

6.  High-resolution melting genotyping of Enterococcus faecium based on multilocus sequence typing derived single nucleotide polymorphisms.

Authors:  Steven Y C Tong; Shirley Xie; Leisha J Richardson; Susan A Ballard; Farshid Dakh; Elizabeth A Grabsch; M Lindsay Grayson; Benjamin P Howden; Paul D R Johnson; Philip M Giffard
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

7.  Effectiveness and limitations of hand hygiene promotion on decreasing healthcare-associated infections.

Authors:  Yee-Chun Chen; Wang-Huei Sheng; Jann-Tay Wang; Shan-Chwen Chang; Hui-Chi Lin; Kuei-Lien Tien; Le-Yin Hsu; Keh-Sung Tsai
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  A Web-based multidrug-resistant organisms surveillance and outbreak detection system with rule-based classification and clustering.

Authors:  Yi-Ju Tseng; Jung-Hsuan Wu; Xiao-Ou Ping; Hui-Chi Lin; Ying-Yu Chen; Rung-Ji Shang; Ming-Yuan Chen; Feipei Lai; Yee-Chun Chen
Journal:  J Med Internet Res       Date:  2012-10-24       Impact factor: 5.428

9.  Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit.

Authors:  Sung-Ching Pan; Jann-Tay Wang; Yee-Chun Chen; Yin-Yin Chang; Mei-Ling Chen; Shan-Chwen Chang
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Beyond the bundle--journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections.

Authors:  Matthew C Exline; Naeem A Ali; Nancy Zikri; Julie E Mangino; Kelly Torrence; Brenda Vermillion; Jamie St Clair; Mark E Lustberg; Preeti Pancholi; Madhuri M Sopirala
Journal:  Crit Care       Date:  2013-03-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.